SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7 | -22.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9 | -43.8% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.9% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $25,000 | +19.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | -27.6% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -23.7% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $38,000 | -15.6% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $45,000 | -25.0% | 5,000 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $60,000 | -4.8% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $63,000 | -19.2% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $78,000 | +66.0% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q3 2020 | $47,000 | +4.4% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $45,000 | +40.6% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $32,000 | -23.8% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $42,000 | -6.7% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $45,000 | -16.7% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $54,000 | +12.5% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $48,000 | -15.8% | 5,000 | 0.0% | 0.01% | -22.2% |
| Q4 2018 | $57,000 | -32.9% | 5,000 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $85,000 | +19.7% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $71,000 | -25.3% | 5,000 | 0.0% | 0.01% | -28.6% |
| Q1 2018 | $95,000 | +15.9% | 5,000 | 0.0% | 0.01% | +27.3% |
| Q4 2017 | $82,000 | +9.3% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $75,000 | +70.5% | 5,000 | 0.0% | 0.01% | +57.1% |
| Q2 2017 | $44,000 | +69.2% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q1 2017 | $26,000 | +73.3% | 5,000 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $15,000 | -34.8% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $23,000 | -20.7% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $29,000 | -3.3% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $30,000 | -34.8% | 5,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $46,000 | +64.3% | 5,000 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $28,000 | -49.1% | 5,000 | 0.0% | 0.01% | -40.0% |
| Q2 2015 | $55,000 | -29.5% | 5,000 | 0.0% | 0.01% | -33.3% |
| Q1 2015 | $78,000 | +2.6% | 5,000 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $76,000 | +40.7% | 5,000 | 0.0% | 0.02% | +25.0% |
| Q3 2014 | $54,000 | -28.9% | 5,000 | 0.0% | 0.01% | -29.4% |
| Q2 2014 | $76,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |